Delivery in 2 weeks! Ready-to-use knockout mice.
Since the launch of the "CRISPR-AI Knockout Mouse Bank," Saiagen has accelerated research progress for over 2,000 research institutions and supported drug development advancements for more than 300 pharmaceutical companies. To provide our customers with faster and more convenient services, we have established 600 lines of living knockout mice (100% success guarantee) and will offer them at a promotional price with a delivery time of two weeks. 【Service Overview】 ■ Mouse Products: KO Mice ■ Deliverables: 1 pair of KO mice / 2 pairs of KO mice ■ Details: 1 male + 1 female / 2 males + 2 females *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【About the Campaign】 ■Period: From May 1 to June 30 ■Target: Customers in Japan ■Free Shipping: Free delivery to customers' animal facilities *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
In 2005, we were established as a contract research organization for pharmaceutical development and a manufacturer of cell-related products. Currently, we have 400 employees worldwide. Our headquarters is located in Silicon Valley, California, USA, with manufacturing bases in Suzhou and Guangzhou, China. In 2016, we opened a branch in Tokyo, Japan. As a leading company in the production of genetically modified animal models, we provide high-quality reagents and tools at reasonable prices. 1. Production of genetically modified animal models: As a leading company in the contract production of rodent animal models, we offer a one-stop service that is optimal for research. Our services cover a wide range, including vector construction, ES cell manipulation, and microinjection production, allowing us to accept contracts for animal model production at any stage of the process. We are also engaged in contract services for animal models using the CRISPR-Cas9 system and artificial nuclease technology. The artificial nuclease technology can save time and costs compared to traditional gene targeting techniques.